Lumexa Imaging Holdings, Inc.

Lumexa Imaging Holdings operates a network of diagnostic imaging centers across the United States, providing outpatient medical imaging services to patients and referring physicians. The company's service portfolio includes magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) scanning, alongside conventional imaging modalities such as X-ray, ultrasound, and mammography. These services support both diagnostic and screening applications across multiple clinical specialties.

The company generates revenue primarily through the provision of imaging services at its owned and operated facilities. Reimbursement flows from insurance companies, government programs, and patient out-of-pocket payments for services rendered. The business model centers on high-utilization imaging equipment and the operational efficiency of outpatient imaging centers.

Lumexa was incorporated in Delaware and established in 2018, with headquarters in Raleigh, North Carolina. The company operates within the medical devices and diagnostic services sector, classified under medical laboratory services. With a market capitalization of approximately $1.5 billion, the company represents a mid-sized participant in the U.S. diagnostic imaging market, though specific details regarding facility count, employee headcount, and geographic distribution of centers are not provided in available data.